CDX (ASX) Ann: Trading Halt

CDX cardiex limited

2.50%

3.9¢

First 18 Last

Share
Profile

Follow
idean

923 Posts.

213

11/09/19

11:17

Post #: 40379410
Share

Originally posted by idean: ↑

Well i hope you get to sell out soon at a profit and never have to deal with CDX or its directors again - and i hope to never be on the same stock forum as you. That's the adult reaction instead of ranting and fighting windmills - nobody really gives a shit - that includes the directors, management, staff and other investors.

Feel free to take your ball and leave the park - go smell the roses and enjoy life, as it seems you've had your share of head-knocks. All the best in your future investing endeavours.

Expand

I hope today is the day that some of you can finally exit the company and invest somewhere else and all the best in your new investments.

I am happy with the CEO and his teams efforts and will continue to hold. I feel whilst the commercialisation of the Atcor technology will have it's ups and downs - its the technology that really excites me as it is unique with zero competitors (and therefore a monopoly), and a large moat in the way of patents.

I can wait 12-24 months....

Originally posted by idean: ↑

Well i hope you get to sell out soon at a profit and never have to deal with CDX or its directors again - and i hope to never be on the same stock forum as you. That's the adult reaction instead of ranting and fighting windmills - nobody really gives a shit - that includes the directors, management, staff and other investors.

Feel free to take your ball and leave the park - go smell the roses and enjoy life, as it seems you've had your share of head-knocks. All the best in your future investing endeavours.

Expand

CDX Price at posting: 3.5¢ Sentiment: Buy Disclosure: Held
6 Upvote

3 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 18 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change -0.001(2.50%)		Mkt cap ! $17.49M

Open	High	Low	Value	Volume
3.9¢	4.0¢	3.8¢	$20.01K	521.6K

Buyers (Bids)

No.	Vol.	Price($)
2	75000	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.2¢	60000	1

View Market Depth

No.	Vol.	Price($)
2	75000	0.038
5	677100	0.037
2	263210	0.036
4	515503	0.035
3	382970	0.034

Price($)	Vol.	No.
0.042	60000	1
0.045	82414	2
0.050	100000	1
0.052	180000	1
0.080	100799	1

Last trade - 15.40pm 27/06/2025 (20 minute delay)

CDX (ASX) Chart

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Boss extends June win streak with boosted Alta Mesa extraction rates

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Boss extends June win streak with boosted Alta Mesa extraction rates

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News